Any Exercise a Mood Booster; MDMA Prescribed Down Under; Climate Change Anxiety Real

Even doing just small amounts of exercise, below the current recommendations, were beneficial for reducing depressive symptoms in older adults. (JAMA Network Open)

A once-daily investigational stimulant — dexmethylphenidate containing CTx-1301 designed to deliver three releases of medication in one tablet — demonstrated “a meaningful trend in improving ADHD symptoms” in a phase III adult trial, said developer Cingulate.

A world first: Australia is offering MDMA (aka Ecstasy or Molly) for individuals with post-traumatic stress disorder. (Washington Post)

People with depression and anxiety were more likely to self-report severe chronic cough in a retrospective study. (Ear, Nose & Throat Journal)

Using stimulants for ADHD in adolescence wasn’t linked with an increased risk for illicit stimulant use in early adulthood, confirming findings from a similar study last week. (JAMA Network Open)

There’s no consensus about how psychedelic drugs work, experts maintained. (STAT)

Mental health respite facilities helped to fill gaps in mental healthcare in some states. (KFF Health News)

Climate change anxiety is a “healthy and empathetic” response, psychologists explained. (Science Alert)

During the COVID-19 pandemic, a third of psychiatrists in Beijing said they were experiencing depression, anxiety, and burnout. (BMC Psychiatry)

Meanwhile, U.S. publicly insured youth were over two times more likely to experience psychiatric boarding during the pandemic compared with pre-pandemic times and were 64% less likely to be discharged to inpatient psychiatric care. (JAMA Network Open)

Depression after traumatic brain injury may be a distinct condition, fMRI data suggested. (Science Translational Medicine)

Please enable JavaScript to view the

comments powered by Disqus.